SPARCL1 and familial pancreatic carcinoma: Elevation of LRG1, SPARCL1, S100A8, Plastin-2 may be of special significance in a small but significant percentage of patients which have increased risk for prolonged development of a disease spectrum that connects AP, RAP, and chronic pancreatitis with emergence of pancreatic cancer.